The development of NAFLD is primarily driven by insulin resistance and dysregulated lipid metabolism, with accumulated ROS subsequently inducing organelle and cellular damage through oxidative stress—representing the “second hit” in NAFLD pathogenesis. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.